Asendin: Advanced Relief for Major Depressive Disorder
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.18 | $35.26 (0%) | 🛒 Add to cart |
| 60 | $1.03 | $70.52 $61.92 (12%) | 🛒 Add to cart |
| 90 | $0.97 | $105.78 $87.72 (17%) | 🛒 Add to cart |
| 120 | $0.95 | $141.04 $113.52 (20%) | 🛒 Add to cart |
| 180 | $0.92 | $211.56 $165.12 (22%) | 🛒 Add to cart |
| 270 | $0.90 | $317.34 $242.52 (24%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $423.12 $317.34 (25%) | 🛒 Add to cart |
Asendin (amoxapine) is a tetracyclic antidepressant indicated for the treatment of major depressive disorder (MDD) in adults. It functions primarily as a norepinephrine reuptake inhibitor, with secondary effects on serotonin, offering a distinct neurochemical profile among antidepressant agents. Clinically, it is recognized for its potential efficacy in cases where first-line selective serotonin reuptake inhibitors (SSRIs) have provided suboptimal response or intolerable side effects. Proper diagnosis and ongoing medical supervision are essential to ensure safe and effective use, tailored to individual patient needs and health profiles.
Features
- Active ingredient: Amoxapine
- Therapeutic class: Tetracyclic antidepressant
- Available in 25 mg, 50 mg, 100 mg, and 150 mg oral tablets
- Mechanism: Primarily inhibits norepinephrine reuptake; moderate serotonin reuptake inhibition
- Bioavailability: High oral absorption, not significantly affected by food
- Half-life: Approximately 8 hours; active metabolite (7-hydroxyamoxapine) extends duration
- Excretion: Primarily renal
Benefits
- Effective reduction of depressive symptoms, including low mood, anhedonia, and fatigue
- May offer faster onset of therapeutic action compared to some SSRIs in certain patients
- Useful alternative when patients experience sexual side effects or weight gain with other antidepressants
- Can improve sleep architecture and reduce anxiety symptoms associated with depression
- Provides a different mechanism of action for treatment-resistant cases
- May have a favorable side effect profile for some individuals regarding weight neutrality
Common use
Asendin is prescribed for the management of major depressive disorder. It is often considered when patients have not responded adequately to first-line antidepressant therapies such as SSRIs or serotonin-norepinephrine reuptake inhibitors (SNRIs). It may also be utilized off-label in certain anxiety disorders or neuropathic pain conditions, though such uses require careful clinical justification and monitoring.
Dosage and direction
Initial dosing typically begins at 25 mg two to three times daily. The dosage may be gradually increased based on therapeutic response and tolerability, often reaching a maintenance range of 100–300 mg per day, divided into two or three doses. Dosages above 300 mg daily are generally not recommended due to increased risk of adverse effects. Elderly patients or those with hepatic or renal impairment may require lower starting doses and slower titration. Tablets should be swallowed whole with water, with or without food.
Precautions
Patients should be monitored for worsening depression, suicidality, or unusual changes in behavior, especially during the initial weeks of therapy or after dosage changes. Use with caution in individuals with a history of seizures, cardiovascular disease, urinary retention, narrow-angle glaucoma, or hyperthyroidism. Regular assessment of liver and renal function may be advised during long-term treatment. Avoid abrupt discontinuation; taper gradually under medical supervision to minimize withdrawal symptoms.
Contraindications
Asendin is contraindicated in patients with known hypersensitivity to amoxapine or any component of the formulation. It should not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to risk of serotonin syndrome. Additional contraindications include recent myocardial infarction, uncompensated heart failure, and certain cardiac arrhythmias.
Possible side effects
Common side effects may include dry mouth, drowsiness, dizziness, constipation, blurred vision, and weight changes. Less frequently, patients may experience orthostatic hypotension, tachycardia, urinary retention, or increased sweating. Rare but serious adverse effects include seizures, neuroleptic malignant syndrome, agranulocytosis, and hepatotoxicity. Any unusual or severe symptoms should be reported to a healthcare provider immediately.
Drug interaction
Asendin may interact with MAOIs (risk of serotonin syndrome), other serotonergic drugs, antihypertensives, CNS depressants (e.g., alcohol, benzodiazepines), anticholinergic agents, and drugs that prolong the QT interval. Concomitant use with strong CYP450 inhibitors or inducers may alter amoxapine plasma concentrations. A comprehensive medication review is essential before initiation.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling up on doses is not recommended.
Overdose
Symptoms of overdose may include severe drowsiness, tachycardia, hypotension, seizures, cardiac arrhythmias, coma, and respiratory depression. Overdose is a medical emergency requiring immediate attention. Treatment is supportive and may include gastric lavage, activated charcoal, and management of specific symptoms such as arrhythmias or seizures.
Storage
Store at room temperature (15–30°C or 59–86°F) in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Individual patient needs and responses may vary.
Reviews
(Note: Simulated patient feedback based on clinical reporting patterns.)
- “Switched to Asendin after two SSRIs didn’t work. Noticeable improvement in energy and mood within three weeks.”
- “Effective, but dry mouth and drowsiness were bothersome initially. These improved after dosage adjustment.”
- “Helped with both depression and anxiety. Appreciate that it didn’t cause weight gain like previous medications.”
- “Requires careful dosing and monitoring, but worth it for the relief it provides.”
- “Would recommend only under close supervision of a psychiatrist familiar with its use.”